Clinical evidence has demonstrated that the anxiolytic effects produced by the selective 5-hydroxytryptamine1A (5-HT1A) receptor agonist, gepirone, increase progressively over one to three weeks of treatment.
Identifer | oai:union.ndltd.org:unt.edu/info:ark/67531/metadc798440 |
Date | 08 1900 |
Creators | Benjamin, Daniel E. (Daniel Ernest) |
Publisher | University of North Texas |
Source Sets | University of North Texas |
Language | English |
Detected Language | English |
Type | Thesis or Dissertation |
Format | Text |
Rights | Public, Copyright, Copyright is held by the author, unless otherwise noted. All rights |
Page generated in 0.0021 seconds